Patents by Inventor Christelle LIARD

Christelle LIARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer vaccine for cats
    Patent number: 10675337
    Abstract: The present invention provides a nucleic acid, or an immunogenic composition thereof, that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment thereof. The present invention also provides methods for triggering an immune response in a cat and methods for treating or preventing a tumor in a cat using the immunogenic composition of the invention.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: June 9, 2020
    Assignee: INVECTYS
    Inventors: Pierre Langlade Demoyen, Simon Wain-Hobson, Christelle Liard
  • Gene electrotransfer into skin cells
    Patent number: 10493154
    Abstract: The present invention relates to methods for transferring a nucleic acid in vivo into skin cells wherein the nucleic acid is injected by intradermal (ID) injection and is electrically transferred into skin cells with a single pulse of a High Voltage, followed, after a defined lag time, by a single pulse of Low Voltage.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: December 3, 2019
    Assignees: INVECTYS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Pierre Langlade Demoyen, Thierry Huet, Christelle Liard, Jessie Thalmensi, Luis M. Mir, Christophe Calvet
  • CANCER VACCINE FOR DOGS
    Publication number: 20190177733
    Abstract: The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a dog telomerase deprived of telomerase catalytic activity, or a fragment thereof.
    Type: Application
    Filed: November 21, 2018
    Publication date: June 13, 2019
    Applicant: INVECTYS
    Inventors: Pierre LANGLADE DEMOYEN, Simon WAIN-HOBSON, Christelle LIARD
  • Telomerase encoding DNA vaccine
    Patent number: 10183065
    Abstract: The invention provides a nucleic acid construct comprising a sequence that encodes a human telomerase reverse transcriptase (hTERT) protein which is devoid of telomerase catalytic activity and of a nucleolar localization signal. The construct is useful triggering an immune response in a subject, against cells that overexpress telomerase, preferably dysplasia cells or tumor cells.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: January 22, 2019
    Assignee: INVECTYS
    Inventors: Pierre Langlade Demoyen, Simon Wain-Hobson, Thierry Huet, Christelle Liard, Elodie Pliquet
  • TELOMERASE ENCODING DNA VACCINE
    Publication number: 20190000946
    Abstract: The invention provides a nucleic acid construct comprising a sequence that encodes a human telomerase reverse transcriptase (hTERT) protein which is devoid of telomerase catalytic activity and of a nucleolar localization signal. The construct is useful triggering an immune response in a subject, against cells that overexpress telomerase, preferably dysplasia cells or tumor cells.
    Type: Application
    Filed: August 24, 2018
    Publication date: January 3, 2019
    Applicant: INVECTYS
    Inventors: Pierre Langlade Demoyen, Simon Wain-Hobson, Thierry Huet, Christelle Liard, Elodie Pliquet
  • Cancer vaccine for dogs
    Patent number: 10138488
    Abstract: The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a dog telomerase deprived of telomerase catalytic activity, or a fragment thereof.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: November 27, 2018
    Assignee: INVECTYS
    Inventors: Pierre Langlade Demoyen, Simon Wain-Hobson, Christelle Liard
  • CANCER VACCINE FOR CATS
    Publication number: 20180271963
    Abstract: The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment thereof.
    Type: Application
    Filed: March 26, 2018
    Publication date: September 27, 2018
    Applicant: INVECTYS
    Inventors: Pierre LANGLADE DEMOYEN, Simon Wain-Hobson, Christelle LIARD
  • Cancer vaccine for cats
    Patent number: 9931387
    Abstract: The present invention provides a nucleic acid, or an immunogenic composition thereof, that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment thereof. The present invention also provides methods for triggering an immune response in a cat and methods for treating or preventing a tumor in a cat using the immunogenic composition of the invention.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: April 3, 2018
    Assignee: INVECTYS
    Inventors: Pierre Langlade Demoyen, Simon Wain-Hobson, Christelle Liard
  • GENE ELECTROTRANSFER INTO SKIN CELLS
    Publication number: 20160279244
    Abstract: The present invention relates to methods for transferring a nucleic acid in vivo into skin cells wherein the nucleic acid is injected by intradermal (ID) injection and is electrically transferred into skin cells with a single pulse of a High Voltage, followed, after a defined lag time, by a single pulse of Low Voltage.
    Type: Application
    Filed: October 28, 2014
    Publication date: September 29, 2016
    Inventors: Pierre Langlade Demoyen, Thierry Huet, Christelle Liard, Jessie Thalmensi, Luis M. Mir, Christophe Calvet
  • TELOMERASE ENCODING DNA VACCINE
    Publication number: 20160263204
    Abstract: The invention provides a nucleic acid construct comprising a sequence that encodes a human telomerase reverse transcriptase (hTERT) protein which is devoid of telomerase catalytic activity and of a nucleolar localization signal. The construct is useful triggering an immune response in a subject, against cells that overexpress telomerase, preferably dysplasia cells or tumor cells.
    Type: Application
    Filed: October 28, 2014
    Publication date: September 15, 2016
    Applicant: INVECTYS
    Inventors: Pierre Langlade Demoyen, Simon Wain-Hobson, Thierry Huet, Christelle Liard, Elodie Pliquet
  • A CANCER VACCINE FOR CATS
    Publication number: 20160051650
    Abstract: The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a cat telomerase deprived of telomerase catalytic activity, or a fragment thereof.
    Type: Application
    Filed: March 28, 2014
    Publication date: February 25, 2016
    Applicant: INVECTYS
    Inventors: Pierre LANGLADE DEMOYEN, Simon WAIN-HOBSON, Christelle LIARD
  • A CANCER VACCINE FOR DOGS
    Publication number: 20160046950
    Abstract: The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a dog telomerase deprived of telomerase catalytic activity, or a fragment thereof.
    Type: Application
    Filed: March 28, 2014
    Publication date: February 18, 2016
    Applicant: INVECTYS
    Inventors: Pierre LANGLADE DEMOYEN, Simon WAIN-HOBSON, Christelle LIARD